Results 201 to 210 of about 64,247 (285)

Paraganglioma in Pregnancy with Recurrent Pregnancy Loss: A Case Report. [PDF]

J ASEAN Fed Endocr Soc
Cheng WM, Hussein Z.
europepmc   +1 more source

Plasma Proteomics Identifies TAOK3 as a Potential Biomarker of Rheumatoid Arthritis Activity and a Novel Therapeutic Target

Arthritis &Rheumatology, Accepted Article.
Objective Bone destruction associated with active rheumatoid arthritis (RA) remains a major therapeutic challenge, with a lack of reliable molecular markers reflecting bone injury. This study aims to identify novel biomarkers linked to bone destruction in active RA through proteomic analysis, providing new strategies for precise monitoring and targeted
Pengfei Xin, Wenzhen Li, Xinyu A, Jun Shen, Xiaohui Meng, Yanqin Bian, Haihui Han, Zheng Xiang, Lei Ran, Songtao Sun, Jun Xie, Tao Yue, Qi Zhu, Xiaoming Zhang, Lu Xie, Lianbo Xiao   +15 more
wiley   +1 more source

Monoclonal Anti-Platelet Factor 4 Antibodies in Recurrent Pregnancy Loss. [PDF]

N Engl J Med
Bavli NR, Kanack AJ, Nishimura Y, Splinter NP, Mauch EE, Ainsworth AJ, Sarode R, McBane RD, Kohlhagen MC, Murray D, Chen D, Pruthi RK, Padmanabhan A.   +12 more
europepmc   +1 more source

Complex chromosomal rearrangements in female carriers experiencing recurrent pregnancy loss or poor obstetric history and literature review [PDF]

Frenny Sheth, Jhanvi Shah, Thomas Liehr, Manisha Desai, Himanshu K. Patel, Jayesh Sheth, Harsh Sheth   +6 more
openalex   +1 more source

“You're this person who's providing light”: Embodied responses to information loss and transition within LGBTQIA+ communities

Journal of the Association for Information Science and Technology, EarlyView.
Abstract This paper reports on findings from 15 semi‐structured interviews with LGBTQIA+ individuals within the United States who have experienced the loss of one or more LGBTQIA+ information spaces. The paper specifically focuses on how such losses occurred and the information transitions experienced by the participants in response to this loss ...
Travis L. Wagner, Vanessa L. Kitzie
wiley   +1 more source

Expert Opinion on the Use of Probiotics in Recurrent Pregnancy Loss. [PDF]

Cureus
Patki A, Kunjimoideen K, Sawankar S, Tyagi R, Hegde V, Budi J.   +5 more
europepmc   +1 more source

Pharmacokinetics, pharmacodynamics and safety of vutiglabridin after multiple oral administrations in healthy female and obese subjects

British Journal of Clinical Pharmacology, EarlyView.
Aims Vutiglabridin (HSG4112) is a novel drug under clinical development for antiobesity treatment. This study aimed to evaluate the pharmacokinetics (PKs) and safety of vutiglabridin after multiple oral administrations in healthy Korean female and obese subjects and explore short‐term pharmacodynamic (PD) responses.
Sooyoun Lee, Hyun Chul Kim, Young Ran Yoon, In‐Jin Jang, Sang‐Ku Yoo, Kyung‐Sang Yu   +5 more
wiley   +1 more source

Exploring novel molecular mechanisms underlying recurrent pregnancy loss in decidual tissues. [PDF]

Sci Rep
Ding H, Gao Y, Gao Y, Chen Y, Liu R, Wang C, Gao Y.   +6 more
europepmc   +1 more source

An open‐label, single‐arm, dose‐escalating concentration–QT study to investigate the cardiac effects and safety of paroxetine in healthy adults

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Paroxetine is a selective serotonin reuptake inhibitor (SSRI), approved for treatment of major depressive disorder and anxiety disorders. Some SSRIs are known to prolong the QT interval; however, clinical evidence to establish a lack of association between paroxetine and corrected QT interval (QTc) prolongation is limited. Therefore, this
Sven C. van Dijkman, Mathieu Félices, Bhaskar Pandurangavittal, Sanman Ghorpade, Caroline Easterbrook, Marcin Zabielski, Oscar Della Pasqua   +6 more
wiley   +1 more source

Immune Dysregulation and Trophoblastic Dysfunction as a Potential Cause of Idiopathic Recurrent Pregnancy Loss. [PDF]

Biology (Basel)
Vasconcelos S, Braga AC, Moustakas I, Cavadas B, Santos M, Caniçais C, Ramalho C, Chuva de Sousa Lopes SM, Marques CJ, Dória S.   +9 more
europepmc   +1 more source